- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01601886
Delivery Room Practice Change Following the Initiation of the NICHD SUPPORT Trial
This study was designed to analyze whether initiation of the NICHD Neonatal Research Network SUPPORT trial was followed by a change in frequency of endotracheal intubation the delivery room in non-participants and whether these changes were associated with changes in management and outcomes.
The investigators hypothesized that the investigators would observe following the initiation of the SUPPORT trial a 33% reduction in the rate of intubation in the delivery room among non-participants preterm infants at Parkland Memorial Hospital.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390-9063
- University of Texas Southwestern
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All babies born at Parkland Memorial Hospital with gestational age at least 24 weeks and less than 35 weeks between 01/2003 and 06/2010
Exclusion Criteria:
- Infants receiving comfort care
- Those with major congenital anomalies
- Those enrolled in the SUPPORT trial
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Before SUPPORT
01/03-06/05
|
During SUPPORT recruitment
07/05-02/09
|
After SUPPORT
03/09-06/10
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endotracheal intubation in the delivery room
Time Frame: In the delivery room (1 day)
|
Frequency of endotracheal intubation in the delivery room
|
In the delivery room (1 day)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Continuous positive airway pressure in the delivery room
Time Frame: In the delivery room (1 day)
|
Frequency of continuous positive airway pressure in the delivery room
|
In the delivery room (1 day)
|
Endotracheal intubation in the first four hours after admission
Time Frame: First four hours after admission
|
Frequency of endotracheal intubation in the first fours after admission to the neonatal intensive care unit
|
First four hours after admission
|
Endotracheal intubation until four hours after admission
Time Frame: Between birth and 4 hours after admission
|
Frequency of endotracheal intubation between birth and four hours after admission in the neonatal intensive care unit
|
Between birth and 4 hours after admission
|
Admninistration of surfactant
Time Frame: Any time between birth and 2 days of age
|
Frequency of admninistration of surfactant any time between birth and 2 days of age
|
Any time between birth and 2 days of age
|
Pneumothorax
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Pneumothorax any time before discharge or transfer or 12 months of age (whichever comes first)
|
Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Bronchopulmonary dysplasia
Time Frame: 28 days
|
Chronic changes on chest radiograph and oxygen requirement (fractional inspiratory concentration of oxygen greater than 0.21) for at least 28 days
|
28 days
|
Necrotizing enterocolitis
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Necrotizing enterocolitis (at least stage II, modified Bell's classification) any time before discharge or transfer or 12 months of age (whichever comes first)
|
Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Duration of mechanical ventilation
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
|
Duration of invasive mechanical ventilation until discharge or transfer or or 12 months of age (whichever comes first)
|
Until discharge or transfer or 12 months of age (whichever comes first)
|
Maximum oxygen concentration
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
|
Maximum inspiratory oxygen concentration until discharge or transfer or 12 months of age (whichever comes first)
|
Until discharge or transfer or 12 months of age (whichever comes first)
|
Severe retinopathy of prematurity
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
|
Severe retinopathy of prematurity (at least stage III, international classification) until discharge or transfer or 12 months of age (whichever comes first)
|
Until discharge or transfer or 12 months of age (whichever comes first)
|
Mortality
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
|
Mortality until discharge or transfer or 12 months of age (whichever comes first)
|
Until discharge or transfer or 12 months of age (whichever comes first)
|
Severe brain lesion on imaging
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Cystic periventricular leukomalacia or grade III or IV intraventricular/ periventricular hemorrhage detected by ultrasonogram any time before discharge or transfer or 12 months of age (whichever comes first)
|
Any time before discharge or transfer or 12 months of age (whichever comes first)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Luc P Brion, MD, University of Texas
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 092010-201
- Velos 12121 (Other Identifier: University of Texas Southwestern)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Thomas Jefferson UniversityCompleted
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland